Literature DB >> 33816613

LncRNA RBM5-AS1 Promotes Osteosarcoma Cell Proliferation, Migration, and Invasion.

Biyong Deng1, Runsang Pan2, Xin Ou1, Taizhe Wang1, Weiguo Wang3, Yingjie Nie4, Houping Chen2.   

Abstract

PURPOSE: Osteosarcoma (Os) is the most frequent malignant tumor of the bone in the pediatric age group, and accumulating evidences show that lncRNAs play a key role in the development of Os. Thus, we investigated the role of RBM5-AS1 and its molecular mechanism.
METHODS: The expression of RBM5-AS1 in Os tissues and cell lines was detected by real-time polymerase chain reaction (QPCR). The effect of RBM5-AS1 on the proliferation of Os cells was detected using CCK8 assays and flow cytometry. The effect of RBM5-AS1 on the migration and invasion of Os cells was detected by transwell assays. And we performed QPCR and western blotting assays to investigate the relationship between RBM5-AS1 and RBM5. Finally, western blotting assays were performed to explore the mechanism of RBM5.
RESULTS: LncRNA RBM5-AS1 was overexpressed in the Os tissues and cell lines. And lncRNA RBM5-AS1 promoted Os cell proliferation, migration, and invasion in vitro and tumor growth in vivo. LncRNA RBM5-AS1 targets RBM5 in Os cells.
CONCLUSION: To sum up, the results showed that lncRNA RBM5-AS1 promotes cell proliferation, migration, and invasion in Os.
Copyright © 2021 Biyong Deng et al.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 33816613      PMCID: PMC7987434          DOI: 10.1155/2021/5271291

Source DB:  PubMed          Journal:  Biomed Res Int            Impact factor:   3.411


  18 in total

Review 1.  Application of Long Noncoding RNAs in Osteosarcoma: Biomarkers and Therapeutic Targets.

Authors:  Zhihong Li; Pengcheng Dou; Tang Liu; Shasha He
Journal:  Cell Physiol Biochem       Date:  2017-07-17

Review 2.  Current and future therapeutic approaches for osteosarcoma.

Authors:  Douglas J Harrison; David S Geller; Jonathan D Gill; Valerae O Lewis; Richard Gorlick
Journal:  Expert Rev Anticancer Ther       Date:  2017-12-14       Impact factor: 4.512

Review 3.  RBM5 as a putative tumor suppressor gene for lung cancer.

Authors:  Leslie C Sutherland; Ke Wang; Andrew G Robinson
Journal:  J Thorac Oncol       Date:  2010-03       Impact factor: 15.609

4.  RBM5-AS1 participates in fracture healing and inhibits apoptosis of bone cells through the up-regulation of β-catenin.

Authors:  Y-Z Huang; L Zhao; C-L Wang; S-J Tian; S Liu; J-F Ge
Journal:  Eur Rev Med Pharmacol Sci       Date:  2018-08       Impact factor: 3.507

Review 5.  Insight Into the Role of Long Noncoding RNA in Cancer Development and Progression.

Authors:  C H Li; Y Chen
Journal:  Int Rev Cell Mol Biol       Date:  2016-05-17       Impact factor: 6.813

6.  RBM5-AS1 Is Critical for Self-Renewal of Colon Cancer Stem-like Cells.

Authors:  Serena Di Cecilia; Fan Zhang; Ana Sancho; SiDe Li; Francesca Aguiló; Yifei Sun; Madhumitha Rengasamy; Weijia Zhang; Luigi Del Vecchio; Francesco Salvatore; Martin J Walsh
Journal:  Cancer Res       Date:  2016-08-12       Impact factor: 12.701

7.  MiR-1297 suppresses pancreatic cancer cell proliferation and metastasis by targeting MTDH.

Authors:  Zili Chen; Yifei Ma; Yaozhen Pan; Haitao Zhu; Chao Yu; Chengyi Sun
Journal:  Mol Cell Probes       Date:  2018-06-13       Impact factor: 2.365

Review 8.  Methods to Study Long Noncoding RNA Biology in Cancer.

Authors:  Man-Li Luo
Journal:  Adv Exp Med Biol       Date:  2016       Impact factor: 2.622

Review 9.  Current and Emerging Targets in Immunotherapy for Osteosarcoma.

Authors:  Shinji Miwa; Toshiharu Shirai; Norio Yamamoto; Katsuhiro Hayashi; Akihiko Takeuchi; Kentaro Igarashi; Hiroyuki Tsuchiya
Journal:  J Oncol       Date:  2019-01-01       Impact factor: 4.375

10.  The tumor suppressor gene RBM5 inhibits lung adenocarcinoma cell growth and induces apoptosis.

Authors:  Chen Shao; Lijing Zhao; Ke Wang; Wei Xu; Jie Zhang; Baoxue Yang
Journal:  World J Surg Oncol       Date:  2012-08-06       Impact factor: 2.754

View more
  3 in total

1.  dbEssLnc: A manually curated database of human and mouse essential lncRNA genes.

Authors:  Ying-Ying Zhang; Wen-Ya Zhang; Xiao-Hong Xin; Pu-Feng Du
Journal:  Comput Struct Biotechnol J       Date:  2022-05-23       Impact factor: 6.155

2.  Bioinformatics analysis of lncRNAs in the occurrence and development of osteosarcoma.

Authors:  Hua Liu; Chenyu Zong; Jiacheng Sun; Haiyang Li; Guangzhen Qin; Xiaojian Wang; Jianwei Zhu; Yang Yang; Qiang Xue; Xianchen Liu
Journal:  Transl Pediatr       Date:  2022-07

3.  Hypoxia-induced lncRNA RBM5-AS1 promotes tumorigenesis via activating Wnt/β-catenin signaling in breast cancer.

Authors:  Xinping Li; Jingyan Yang; Ruiqi Ni; Jintian Chen; Yanhao Zhou; Hao Song; Liang Jin; Yi Pan
Journal:  Cell Death Dis       Date:  2022-02-02       Impact factor: 8.469

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.